GCGiovanni Candiano

Giovanni Candiano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giovanni Candiano has a total of 432 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteomic profiling of human amnion for preterm birth biomarker discovery

    by Maurizio Bruschi, Martina Bartolucci, Andrea Petretto, Francesca Buffelli, Xhuliana Kajana, Alessandro Parodi, Riccardo Carbone, Ezio Fulcheri, Luca Antonio Ramenghi, Isabella Panfoli, et al.

    Spontaneous preterm birth (PTB) complicates about 12% of pregnancies worldwide, remaining the main cause of neonatal morbidity and mortality. Spontaneous preterm birth PTBs is often caused by microbial-induced preterm labor, mediated by an inflammatory process threatening both maternal and newborn health. In search for novel predictive biomarkers of PTB and preterm prelabor rupture of the membranes (pPROM), and to improve understanding of infection related PTB, we performed an untargeted mass spectrometry discovery study on 51 bioptic mid zone amnion samples from premature babies. A total of 6352 proteins were identified. Bioinformatics analyses revealed a ranked core of 159 proteins maximizing the discrimination between the selected clinical stratification groups allowing to distinguish conditions of absent (FIR 0) from maximal Fetal Inflammatory Response (FIR 3) stratified in function of Maternal Inflammatory Response (MIR) grade. Matrix metallopeptidase-9 (MMP-9) was the top differentially expressed protein. Gene Ontology enrichment analysis of the core proteins showed significant changes in the biological pathways associated to inflammation and regulation of immune and infection response. Data suggest that the conditions determining PTB would be a transversal event, secondary to the maternal inflammatory response causing a breakdown in fetal-maternal tolerance, with fetal inflammation being more severe than maternal one. We also highlight matrix metallopeptidase-9 as a potential predictive biomarker of PTB that can be assayed in the maternal serum, for future investigation.


  • Why do premature newborn infants display elevated blood adenosine levels?

    by Isabella Panfoli, Michela Cassanello, Matteo Bruschettini, Marina Colella, Roberto Cerone, Silvia Ravera, Daniela Calzia, Giovanni Candiano, Luca Ramenghi


  • Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters

    by Corrado Murtas, Maurizio Bruschi, Giovanni Candiano, Alice Bonanni, Gian Marco Ghiggeri


  • Human urinary exosome proteome unveils its aerobic respiratory ability

    by Maurizio Bruschi, Laura Santucci, Silvia Ravera, Giovanni Candiano, Martina Bartolucci, Daniela Calzia, Chiara Lavarello, Elvira Inglese, Luca A. Ramenghi, Andrea Petretto, et al.


  • Urine proteome analysis in Dent's disease shows high selective changes potentially involved in chronic renal damage

    by Laura Santucci, Giovanni Candiano, Franca Anglani, Maurizio Bruschi, Enrica Tosetto, Daniela Cremasco, Luisa Murer, Chiara D'Ambrosio, Andrea Scaloni, Andrea Petretto, et al.


  • Open Access

    Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine

    by Laura Santucci, Maurizio Bruschi, Giovanni Candiano, Francesca Lugani, Andrea Petretto, Alice Bonanni, Gian Marco Ghiggeri

    Urine proteome is a potential source of information in renal diseases, and it is considered a natural area of investigation for biomarkers. Technology developments have markedly increased the power analysis on urinary proteins, and it is time to confront methodologies and results of major studies on the topics. This is a first part of a series of reviews that will focus on the urine proteome as a site for detecting biomarkers of renal diseases; the theme of the first review concerns methodological aspects applied to normal urine. Main issues are techniques for urine pretreatment, separation of exosomes, use of combinatorial peptide ligand libraries, mass spectrometry approaches, and analysis of data sets. Available studies show important differences, suggesting a major confounding effect of the technologies utilized for analysis. The objective is to obtain consensus about which approaches should be utilized for studying urine proteome in renal diseases.


  • Open Access

    Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants

    by Isabella Panfoli, Silvia Ravera, Marina Podestà, Claudia Cossu, Laura Santucci, Martina Bartolucci, Maurizio Bruschi, Daniela Calzia, Federica Sabatini, Matteo Bruschettini, et al.

    Exosomes are secreted nanovesicles that are able to transfer RNA and proteins to target cells. The emerging role of mesenchymal stem cell (MSC) exosomes as promoters of aerobic ATP synthesis restoration in damaged cells, prompted us to assess whether they contain an extramitochondrial aerobic respiration capacity. Exosomes were isolated from culture medium of human MSCs from umbilical cord of ≥37‐wk‐old newborns or between 28‐ to 30‐wk‐old newborns ( i.e. , term or preterm infants). Characterization of samples was conducted by cytofluorometry. Oxidative phosphorylation capacity was assessed by Western blot analysis, oximetry, and luminometric and fluorometric analyses. MSC exosomes express functional respiratory complexes I, IV, and V, consuming oxygen. ATP synthesis was only detectable in exosomes from term newborns, suggestive of a specific mechanism that is not completed at an early gestational age. Activities are outward facing and comparable to those detected in mitochondria isolated from term MSCs. MSC exosomes display an unsuspected aerobic respiratory ability independent of whole mitochondria. This may be relevant for their ability to rescue cell bioenergetics. The differential oxidative metabolism of preterm vs. term exosomes sheds new light on the preterm newborn's clinical vulnerability. A reduced ability to repair damaged tissue and an increased capability to cope with anoxic environment for preterm infants can be envisaged.—Panfoli, I., Ravera, S., Podestà, M., Cossu, C., Santucci, L., Bartolucci, M., Bruschi, M., Calzia, D., Sabatini, F., Bruschettini, M., Ramenghi, L. A., Romantsik, O., Marimpietri, D., Pistoia, V., Ghiggeri, G., Frassoni, F., Candiano, G. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J. 30, 1416–1424 (2016). www.fasebj.org


  • Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference

    by Alice Bonanni, Augusto Vaglio, Maurizio Bruschi, Renato Alberto Sinico, Lorenzo Cavagna, Gabriella Moroni, Franco Franceschini, Landino Allegri, Federico Pratesi, Paola Migliorini, et al.


  • Open Access

    Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2)

    by Maurizio Bruschi, Maricla Galetti, Renato Alberto Sinico, Gabriella Moroni, Alice Bonanni, Antonella Radice, Angela Tincani, Federico Pratesi, Paola Migliorini, Corrado Murtas, et al.

    Glomerular planted antigens (histones, DNA, and C1q) are potential targets of autoimmunity in lupus nephritis (LN). However, the characterization of these antigens in human glomeruli in vivo remains inconsistent. We eluted glomerular autoantibodies recognizing planted antigens from laser-microdissected renal biopsy samples of 20 patients with LN. Prevalent antibody isotypes were defined, levels were determined, and glomerular colocalization was investigated. Renal and circulating antibodies were matched, and serum levels were compared in 104 patients with LN, 84 patients with SLE without LN, and 50 patients with rheumatoid arthritis (RA). Autoantibodies against podocyte antigens (anti–α-enolase/antiannexin AI) were also investigated. IgG2 autoantibodies against DNA, histones (H2A, H3, and H4), and C1q were detected in 50%, 55%, and 70% of biopsy samples, respectively. Anti-DNA IgG3 was the unique non-IgG2 anti-DNA deposit, and anti-C1q IgG4 was mainly detected in subepithelial membranous deposits. Anti-H3, anti-DNA, and anti-C1q IgG2 autoantibodies were also prevalent in LN serum, which also contained IgG3 against the antigen panel and anti-C1q IgG4. Serum and glomerular levels of autoantibodies were not strictly associated. High serum levels of all autoantibodies detected, including anti–α-enolase and antiannexin AI, identified LN versus SLE and RA. Anti-H3 and anti–α-enolase IgG2 levels had the most remarkable increase in LN serum and represented a discriminating feature of LN in principal component analysis. The highest levels of these two autoantibodies were also associated with proteinuria>3.5 g/24 hours and creatinine>1.2 mg/dl. Our findings suggest that timely autoantibody characterization might allow outcome prediction and targeted therapies for patients with nephritis.


  • The human urinary exosome as a potential metabolic effector cargo

    by Maurizio Bruschi, Silvia Ravera, Laura Santucci, Giovanni Candiano, Martina Bartolucci, Daniela Calzia, Chiara Lavarello, Elvira Inglese, Andrea Petretto, Gianmarco Ghiggeri, et al.

    (2015). The human urinary exosome as a potential metabolic effector cargo. Expert Review of Proteomics: Vol. 12, No. 4, pp. 425-432. doi: 10.1586/14789450.2015.1055324